# Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

> **NCT04209218** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 1988 (estimated)

## Conditions studied

- Lung Cancer
- Surgery
- Blood Pressure Management
- Dexamethasone
- Overall Survival
- Postoperative Complications

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** Targeted blood pressure management
- **DRUG:** Placebo
- **OTHER:** Routine blood presure management

## Key facts

- **NCT ID:** NCT04209218
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-04-07
- **Primary completion:** 2026-12
- **Final completion:** 2029-12
- **Target enrollment:** 1988 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04209218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04209218, "Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04209218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*